Restrepo Valencia, Cesar A.Aguirre Arango, Jose V.Musso, Carlos G.2020-01-172020-01-17201911787058https://hdl.handle.net/20.500.12442/4533In a high percentage of patients with chronic kidney disease (CKD) low levels of vitamin D are detected. The purpose of this study was to evaluate if the native vitamin D therapy (cholecalciferol) in the patients with stage 3 and hypovitaminosis D allows to modify markers of bone and mineral metabolism once normal serum levels have been achieved.pdfengAttribution-NonCommercial-NoDerivatives 4.0 InternacionalVitamin DCholecalciferolChronic kidney diseaseHypovitaminosis Darticleinfo:eu-repo/semantics/openAccess